FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1636699277> ?p ?o ?g. }

• W1636699277 endingPage "6480" @default.
• W1636699277 startingPage "6472" @default.
• W1636699277 abstract "Mutated epidermal growth factor receptor (EGF-RvIII, DeltaEGF-R, and de2-7 EGF-R) is the result of an 801-bp deletion within the extracellular domain of wild-type EGF-R and is expressed by breast carcinomas, but not by normal breast tissues. EGF-RvIII is expressed both on the surface and in the cytoplasm of tumor cells. Thus, EGF-RvIII is a potential tumor-specific target for both Abs and T cells. However, it is not known whether breast cancer patients can raise immune responses to EGF-RvIII expressed by their tumors. The demonstration of EGF-RvIII-specific immune responses in patients would suggest that immunization of patients with EGF-RvIII vaccines is feasible, because these vaccines may boost a pre-existing immune response. We have evaluated humoral and cellular immune responses to EGF-RvIII in 16 breast cancer patients and three healthy donors. Seven of 16 patients developed EGF-RvIII-specific Abs that bound to isolated EGF-RvIII protein or the protein expressed by EGF-RvIII-transfected mouse fibroblasts. The Abs that bound to EGF-RvIII did not bind to wild-type EGF-R, and anti-EGF-RvIII Abs were not found in the sera of healthy donors. Three patients had EGF-RvIII peptide-specific lymphoproliferative responses, and two of these patients also had humoral immune responses. Humoral and cellular immune responses correlated with EGF-RvIII expression by patients' tumors in most cases. These studies demonstrate that breast cancer patients specifically recognize EGF-RvIII with an overall immune response rate of 50%, suggesting that patients may benefit from vaccination against EGF-RvIII, boosting pre-existing immune responses." @default.
• W1636699277 created "2016-06-24" @default.
• W1636699277 creator A5005537242 @default.
• W1636699277 creator A5006285859 @default.
• W1636699277 creator A5006632858 @default.
• W1636699277 creator A5012012199 @default.
• W1636699277 creator A5012401963 @default.
• W1636699277 creator A5021976445 @default.
• W1636699277 creator A5027075360 @default.
• W1636699277 creator A5028089372 @default.
• W1636699277 creator A5038094731 @default.
• W1636699277 creator A5044465742 @default.
• W1636699277 creator A5051242364 @default.
• W1636699277 creator A5052264374 @default.
• W1636699277 creator A5059941996 @default.
• W1636699277 creator A5064458568 @default.
• W1636699277 creator A5067054494 @default.
• W1636699277 creator A5070591384 @default.
• W1636699277 creator A5087233281 @default.
• W1636699277 creator A5090410720 @default.
• W1636699277 date "2004-11-15" @default.
• W1636699277 modified "2023-10-17" @default.
• W1636699277 title "Immune Responses of Breast Cancer Patients to Mutated Epidermal Growth Factor Receptor (EGF-RvIII, ΔEGF-R, and de2–7 EGF-R)" @default.
• W1636699277 cites W1784906962 @default.
• W1636699277 cites W1930782380 @default.
• W1636699277 cites W1967294666 @default.
• W1636699277 cites W1973800266 @default.
• W1636699277 cites W1975878941 @default.
• W1636699277 cites W2012053348 @default.
• W1636699277 cites W2012852944 @default.
• W1636699277 cites W2013607199 @default.
• W1636699277 cites W2013878898 @default.
• W1636699277 cites W2024441247 @default.
• W1636699277 cites W2028000100 @default.
• W1636699277 cites W2029315636 @default.
• W1636699277 cites W2036463478 @default.
• W1636699277 cites W2036572896 @default.
• W1636699277 cites W2043732412 @default.
• W1636699277 cites W2052481453 @default.
• W1636699277 cites W2054829675 @default.
• W1636699277 cites W2056102876 @default.
• W1636699277 cites W2059483129 @default.
• W1636699277 cites W2066848701 @default.
• W1636699277 cites W2123099415 @default.
• W1636699277 cites W2130184077 @default.
• W1636699277 cites W2134283359 @default.
• W1636699277 cites W2139937771 @default.
• W1636699277 cites W4253033201 @default.
• W1636699277 doi "https://doi.org/10.4049/jimmunol.173.10.6472" @default.
• W1636699277 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15528389" @default.
• W1636699277 hasPublicationYear "2004" @default.
• W1636699277 type Work @default.
• W1636699277 sameAs 1636699277 @default.
• W1636699277 citedByCount "29" @default.
• W1636699277 countsByYear W16366992772012 @default.
• W1636699277 countsByYear W16366992772013 @default.
• W1636699277 countsByYear W16366992772014 @default.
• W1636699277 countsByYear W16366992772015 @default.
• W1636699277 countsByYear W16366992772016 @default.
• W1636699277 countsByYear W16366992772017 @default.
• W1636699277 countsByYear W16366992772018 @default.
• W1636699277 countsByYear W16366992772019 @default.
• W1636699277 countsByYear W16366992772020 @default.
• W1636699277 countsByYear W16366992772022 @default.
• W1636699277 countsByYear W16366992772023 @default.
• W1636699277 crossrefType "journal-article" @default.
• W1636699277 hasAuthorship W1636699277A5005537242 @default.
• W1636699277 hasAuthorship W1636699277A5006285859 @default.
• W1636699277 hasAuthorship W1636699277A5006632858 @default.
• W1636699277 hasAuthorship W1636699277A5012012199 @default.
• W1636699277 hasAuthorship W1636699277A5012401963 @default.
• W1636699277 hasAuthorship W1636699277A5021976445 @default.
• W1636699277 hasAuthorship W1636699277A5027075360 @default.
• W1636699277 hasAuthorship W1636699277A5028089372 @default.
• W1636699277 hasAuthorship W1636699277A5038094731 @default.
• W1636699277 hasAuthorship W1636699277A5044465742 @default.
• W1636699277 hasAuthorship W1636699277A5051242364 @default.
• W1636699277 hasAuthorship W1636699277A5052264374 @default.
• W1636699277 hasAuthorship W1636699277A5059941996 @default.
• W1636699277 hasAuthorship W1636699277A5064458568 @default.
• W1636699277 hasAuthorship W1636699277A5067054494 @default.
• W1636699277 hasAuthorship W1636699277A5070591384 @default.
• W1636699277 hasAuthorship W1636699277A5087233281 @default.
• W1636699277 hasAuthorship W1636699277A5090410720 @default.
• W1636699277 hasBestOaLocation W16366992771 @default.
• W1636699277 hasConcept C121608353 @default.
• W1636699277 hasConcept C126322002 @default.
• W1636699277 hasConcept C170493617 @default.
• W1636699277 hasConcept C193419808 @default.
• W1636699277 hasConcept C203014093 @default.
• W1636699277 hasConcept C2776362946 @default.
• W1636699277 hasConcept C2779438470 @default.
• W1636699277 hasConcept C502942594 @default.
• W1636699277 hasConcept C530470458 @default.
• W1636699277 hasConcept C71924100 @default.
• W1636699277 hasConcept C86803240 @default.
• W1636699277 hasConcept C8891405 @default.
• W1636699277 hasConceptScore W1636699277C121608353 @default.

• next